UBS O'Connor’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $856K | Sell |
73,441
-114,348
| -61% | -$1.33M | 0.04% | 223 |
|
|
2025
Q1 | $1.4M | Sell |
187,789
-26,040
| -12% | -$193K | 0.04% | 144 |
|
|
2024
Q4 | $1.28M | Buy |
213,829
+48,555
| +29% | +$291K | 0.03% | 203 |
|
|
2024
Q3 | $846K | Buy |
165,274
+99,529
| +151% | +$510K | 0.02% | 292 |
|
|
2024
Q2 | $238K | Hold |
65,745
| – | – | 0.01% | 390 |
|
|
2024
Q1 | $211K | Sell |
65,745
-100,000
| -60% | -$321K | 0.01% | 371 |
|
|
2023
Q4 | $812K | Sell |
165,745
-35,595
| -18% | -$174K | 0.03% | 290 |
|
|
2023
Q3 | $1.1M | Buy |
201,340
+1,500
| +0.8% | +$8.18K | 0.02% | 317 |
|
|
2023
Q2 | $1.34M | Buy |
199,840
+21,254
| +12% | +$143K | 0.03% | 348 |
|
|
2023
Q1 | $1.58M | Buy |
+178,586
| New | +$1.58M | 0.04% | 359 |
|
|
2022
Q4 | – | Sell |
-143,490
| Closed | -$1.02M | – | 18 |
|
|
2022
Q3 | $1.02M | Sell |
143,490
-70,000
| -33% | -$499K | 0.01% | 734 |
|
|
2022
Q2 | $1.73M | Buy |
+213,490
| New | +$1.73M | 0.02% | 679 |
|